RadNet, Inc. Common Stock (RDNT) — Analysis Summary
RadNet, Inc. Common Stock (RDNT) has a market cap of $4.98B with year-over-year revenue growth of +11.5%. Net margin stands at -0.9%. The stock trades at a P/E ratio of -350.8.
Key Takeaways
- Revenue changed +11.5% year-over-year
- Net margin of -0.9%
- P/E ratio of -350.8
Compared to other companies in the SERVICES-MEDICAL LABORATORIES sector, RDNT posted revenue growth of +11.5% and trades at a P/E of -350.8.
RadNet, Inc. Common Stock (RDNT)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at 0.9x — earnings do not cover interest payments
Debt/EBITDA at 4.9x — elevated leverage
Operating margin (2.9%) exceeds gross margin (0.0%) — check for other operating income or data classification issues
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostic.
Sector
SERVICES-MEDICAL LABORATORIES
Employees
11,264
Headquarters
LOS ANGELES, CA
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.